Children Learning About Secondhand Smoke (CLASS II): A Pilot Cluster Randomized Controlled Trial.
Bangladesh
/ epidemiology
Child
Cluster Analysis
Cost-Benefit Analysis
/ methods
Cotinine
/ analysis
Female
Follow-Up Studies
Humans
Learning
Male
Outcome Assessment, Health Care
/ economics
Pilot Projects
Saliva
/ chemistry
Schools
/ economics
Students
/ psychology
Tobacco Smoke Pollution
/ analysis
Journal
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
ISSN: 1469-994X
Titre abrégé: Nicotine Tob Res
Pays: England
ID NLM: 9815751
Informations de publication
Date de publication:
17 04 2019
17 04 2019
Historique:
received:
21
11
2017
accepted:
15
05
2018
pubmed:
18
5
2018
medline:
31
3
2020
entrez:
18
5
2018
Statut:
ppublish
Résumé
Children exposed to secondhand smoke (SHS) are at increased risk of respiratory illnesses. We piloted a Smoke Free Intervention (SFI) and trial methods before investigating its effectiveness and cost-effectiveness in primary school children. In a pilot cluster randomized controlled trial in Bangladesh, primary schools were allocated to usual education (control) or SFI, using minimization. Year-5 children were recruited. Masking treatment allocation was not possible. Delivered by schoolteachers, SFI consisted of two 45-min and four 15-min educational sessions. Our primary outcome was SHS exposure at two months post randomization, verified by children's salivary cotinine. The trial is registered at ISRCTN.com; ISRCTN68690577. Between April 1, 2015 and June 30, 2015, we recruited 12 schools. Of the 484 children present in Year-5, 481 consented. Six schools were allocated to both SFI (n = 245) and to usual education only (n = 236). Of them, 450 children (SFI = 229; control = 221) who had cotinine levels indicative of SHS exposure were followed-up. All schools were retained, 91% children (208/229) in SFI and 88% (194/221) in the control arm completed primary outcome assessment. Their mean cotinine at the cluster level was 0.53 ng/ml (SD 0.36) in SFI and 1.84 ng/ml (SD 1.49) in the control arm-a mean difference of -1.31 ng/ml (95% CI = -2.86 to 0.24). It was feasible to recruit, randomize, and retain primary schools and children in our trial. Our study, though not powered to detect differences in mean cotinine between the two arms, provides estimates to inform the likely effect size for future trials. In countries with high smoking prevalence, children remain at risk of many conditions due to secondhand smoke exposure. There is little empirical evidence on the effectiveness and cost-effectiveness of interventions that can reduce their exposure to secondhand smoke at homes. CLASS II trial found that a school-based intervention (SFI) has the potential to reduce children's exposure to SHS-an approach that has been rarely used, but has considerable merit in school-based contexts. CLASS II trial provides key information to conduct a future definitive trial in this area of public health, which despite its importance has so far received little attention.
Identifiants
pubmed: 29771390
pii: 4996673
doi: 10.1093/ntr/nty090
pmc: PMC6468126
doi:
Substances chimiques
Tobacco Smoke Pollution
0
Cotinine
K5161X06LL
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
670-677Subventions
Organisme : Medical Research Council
ID : MR/K023195/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M020533/1
Pays : United Kingdom
Informations de copyright
© The Author(s) 2018. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco.
Références
Lancet. 2003 Jun 7;361(9373):1939-44
pubmed: 12801737
Adv Exp Med Biol. 2003;537:353-69
pubmed: 14995047
BMJ Open. 2015 Aug 25;5(8):e008749
pubmed: 26307620
Lancet. 2011 Jan 8;377(9760):139-46
pubmed: 21112082
Lancet. 2014 May 3;383(9928):1549-60
pubmed: 24680633
Pediatrics. 2009 Oct;124(4):e633-9
pubmed: 19736265
Public Health Nutr. 2016 Sep;19(13):2393-403
pubmed: 27297518
Cochrane Database Syst Rev. 2016 Feb 04;2:CD005992
pubmed: 26842828
Tob Control. 2016 Dec;25(e2):e95-e100
pubmed: 26869598
BMJ Open. 2014 Nov 24;4(11):e006554
pubmed: 25421340
Cochrane Database Syst Rev. 2014 Mar 01;(3):CD001746
pubmed: 24671922
JAMA Pediatr. 2016 Feb;170(2):138-47
pubmed: 26719991
Cochrane Database Syst Rev. 2008 Oct 08;(4):CD001746
pubmed: 18843622
Int J Environ Res Public Health. 2015 Dec 18;12(12):16043-59
pubmed: 26694440
Thorax. 2011 Oct;66(10):847-55
pubmed: 21325144
Ann Epidemiol. 2013 Oct;23(10):652-61
pubmed: 23969303
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
Acta Paediatr. 2014 Apr;103(4):426-35
pubmed: 24761459
Nicotine Tob Res. 2015 Dec;17(12):1465-72
pubmed: 25634936
Pediatrics. 2014 Apr;133(4):698-714
pubmed: 24664094
Health Educ Res. 2011 Apr;26(2):265-82
pubmed: 21273185
Chest. 2016 Feb;149(2):552-561
pubmed: 26502117
Prev Med. 1996 Jul-Aug;25(4):486-94
pubmed: 8812826
Trials. 2013 Sep 13;14:295
pubmed: 24034853
Epidemiol Infect. 2015 Nov;143(15):3158-72
pubmed: 26118887